YMAB
Y-mAbs Therapeutics
YMAB
YMAB
Delisted
YMAB was delisted on the 15th of September, 2025.
96 hedge funds and large institutions have $126M invested in Y-mAbs Therapeutics in 2025 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 28 increasing their positions, 36 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
96
Holders Change
-6
Holders Change %
-5.88%
% of All Funds
1.29%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
13
Increased
28
Reduced
36
Closed
19
Calls
$151K
Puts
$2K
Net Calls
+$149K
Net Calls Change
-$13K
Top Buyers
Top Sellers
1 |
Pictet Asset Management
Carouge,
Switzerland
|
-$1.96M |
2 |
Millennium Management
New York
|
-$1.47M |
3 |
Morgan Stanley
New York
|
-$936K |
4 |
Wellington Management Group
Boston,
Massachusetts
|
-$904K |
5 |
BlackRock
New York
|
-$694K |